title: Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma.
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States.
authors.forename: Ju Dong
authors.initials: JD
authors.lastname: Yang
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Scottsdale, AZ, United States.
authors.forename: Bashar A
authors.initials: BA
authors.lastname: Aqel
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Jacksonville, FL, United States.
authors.forename: Surakit
authors.initials: S
authors.lastname: Pungpapong
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States.
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Gores
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States.
authors.forename: Lewis R
authors.initials: LR
authors.lastname: Roberts
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States. Electronic address: Leise.Michael@mayo.edu.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Leise
mesh_terms: D000998:Antiviral Agents; D006528:Carcinoma, Hepatocellular; D006526:Hepatitis C; D019698:Hepatitis C, Chronic; D006801:Humans; D008113:Liver Neoplasms; D016031:Liver Transplantation; D009364:Neoplasm Recurrence, Local; D012008:Recurrence
chemical_list: D000998:Antiviral Agents